JD.com Launches "Healthy China Medical Grant Project"

there is no overall well-off without the health of the whole people. 2020 is the year when China has built a well-off society in an all-round way, and it is also the year when the country's anti-poverty efforts will be decided, in which healthy poverty alleviation is an important way to achieve accurate poverty alleviation.In order to effectively reduce the burden of drug use by the poor, on May 9, china's Social Poverty Reduction Network, together with JD.com Health and JD.com Public Welfare, launched the "Healthy China medical subsidy project". The project will provide a subsidy of 1,000 yuan per person per year for the purchase of medicines for poor households (including those who have been lifted out of poverty) in the country, which can be used when purchasing medicines from designated catalogues.By the time it was launched, the program's list of subsidized medicines had more than 350 drugs, covering hundreds of common and chronic diseases, including cardiovascular and cerebrovascular diseases, cold fever, gastrointestinal diseases, and would rapidly expand to new specialties and rare diseases in the future. The project, which is expected to cover more than 30 million people over the next three to five years, will effectively reduce the burden of medical expenses for the poor and help curb the phenomenon of disease-related poverty and return to poverty, which is currently the most widespread, largest number of benefits and the largest subsidy funds for health-poverty alleviation projects in the country.The poverty-relief groups can receive a subsidy of 1,000 yuan per person per year for drug purchasebenefit from the national precision poverty alleviation policy, and the rate of poverty in China has dropped sharply from 10.2% in 2012 to 0.6% by the end of 2019. In terms of health and poverty alleviation, in 2020, the number of special treatments for major diseases among the rural poor nationwide will increase to 30, the proportion of insurance reimbursements for major diseases will be increased to 60%, and the proportion of reimbursements for hospital medical expenses for the rural poor will be increased to 90%, to a large extent, which will alleviate the problems such as the high cost of medical care for poor households.However, there are many outpatient drugs, often spare drugs are not covered by the rural poor medical insurance reimbursement; Data show that China's disease-caused poverty, the return to poverty accounted for more than 40% of the total population of poverty, as the working poor gradually out of poverty, this proportion will increase. To achieve the goal of poverty eradication on schedule and to prevent the return of people to poverty due to illness has become a key part of the decisive stage.Under the guidance of the China Association for the Promotion of Poverty Relief Volunteering, relying on the China Social Poverty Reduction Network, the "Healthy China Medical Assistance Project" will accurately identify the identity of the poor people throughout the country and identify the recipients, and JD.com Health will provide 1000 yuan per person per year in drug subsidy funds for the recipients, who can be used when purchasing medicines in the subsidy catalogue through designated channels.The project's designated online drug purchase channels for JD.com Health's own retail pharmacy - JD.com Pharmacy, users purchased drugs by JD.com logistics, distribution coverage can cover most parts of the country; The project will give priority to the launch of online platform subsidies, offline to take parts of the pilot, and then gradually promote the model to the whole country.At present, JD.com Health has reached cooperation with the first 11 pharmaceutical companies, such as Hangzhou Minsheng Health Pharmaceuticals, Tianshili Pharmaceutical Group, Su-Chinese Pharmaceutical Group, Enway Pharmaceuticals, Sunflower Pharmaceuticals Group, Lunan Pharmaceutical Group, Shanghai Chinese Pharmaceuticals, Yunnan White Pharmaceuticals Group, Yangzijiang Pharmaceuticals Group, Xi'an Yangsen Pharmaceuticals, Yabao Pharmaceuticals Group, etc., to screen out more than 350 kinds of drugs and determine the proportion of subsidies. Project cooperative pharmaceutical enterprises and subsidy catalogue drugs will continue to expand and increase with the start of the project. (
arterial
)